Hillman Cancer Institute at UPMC — Pittsburgh, Pennsylvania

Hillman Cancer Institute at UPMC is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Hillman Cancer Institute at UPMC has participated in 2 clinical trials.

Therapeutic areas: Mantle Cell Lymphoma, Myelodysplastic Syndromes.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hillman Cancer Institute at UPMC?

Hillman Cancer Institute at UPMC has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hillman Cancer Institute at UPMC conducted?

Hillman Cancer Institute at UPMC has 2 clinical trials on record. Their work covers Mantle Cell Lymphoma, Myelodysplastic Syndromes.

Is Hillman Cancer Institute at UPMC accredited by Crixeo Health?

Hillman Cancer Institute at UPMC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hillman Cancer Institute at UPMC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.